![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2021
Riesinger, Lisa; Strobl, Claudia; Leistner, David M.; Gori, Tommaso; Akin, Ibrahim; Mehr, Michael; Kellnar, Antonia; Mahabadi, Amir A.; Bogossian, Harilaos; Block, Michael; Edelmann, Frank; Sarafoff, Nikolaus; Sibbing, Dirk; Ince, Hüseyin; Rassaf, Tienush; Mansmann, Ulrich 
ORCID: https://orcid.org/0000-0002-9955-8906; Mehilli, Julinda; Kääb, Stefan; Hausleiter, Jörg; Massberg, Steffen und Wakili, Reza
(2021):
Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF). Rationale and design of the prospective randomized parallel-group, open-label, blinded-endpoint, superiority, multicenter-trial of a triple therapy versus a dual therapy in patients with Atrial Fibrillation and Acute Coronary Syndrome undergoing coronary stenting.
In: IJC Heart & Vessels, Bd. 35, 100810
[PDF, 569kB]
ORCID: https://orcid.org/0000-0002-9955-8906; Mehilli, Julinda; Kääb, Stefan; Hausleiter, Jörg; Massberg, Steffen und Wakili, Reza
(2021):
Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF). Rationale and design of the prospective randomized parallel-group, open-label, blinded-endpoint, superiority, multicenter-trial of a triple therapy versus a dual therapy in patients with Atrial Fibrillation and Acute Coronary Syndrome undergoing coronary stenting.
In: IJC Heart & Vessels, Bd. 35, 100810
[PDF, 569kB]
Riesinger, Lisa; Strobl, Claudia; Leistner, David M.; Gori, Tommaso; Akin, Ibrahim; Mehr, Michael; Kellnar, Antonia; Mahabadi, Amir A.; Bogossian, Harilaos; Block, Michael; Edelmann, Frank; Sarafoff, Nikolaus; Sibbing, Dirk; Ince, Hueseyin; Rassaf, Tienush; Mansmann, Ulrich; Mehilli, Julinda; Kaeaeb, Stefan; Hausleiter, Joerg; Massberg, Steffen und Wakili, Reza
(2021):
Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF) Rationale and design of the prospective randomized parallel-group, open-label, blinded-endpoint, superiority, multicenter-trial of a triple therapy versus a dual therapy in patients with Atrial Fibrillation and Acute Coronary Syndrome undergoing coronary stenting.
In: Ijc Heart & Vasculature, Bd. 35, 100810
2014
Aljutaili, Majed; Becker, Christian; Witt, Sabine; Holle, Rolf; Leidl, Reiner ORCID: https://orcid.org/0000-0002-7115-7510; Block, Michael; Brachmann, Johannes; Silber, Sigmund; Bestehorn, Kurt und Stollenwerk, Björn
(2014):
Should health insurers target prevention of cardiovascular disease? A cost-effectiveness analysis of an individualised programme in Germany based on routine data.
In: BMC Health Services Research
14:263
[PDF, 761kB]
ORCID: https://orcid.org/0000-0002-7115-7510; Block, Michael; Brachmann, Johannes; Silber, Sigmund; Bestehorn, Kurt und Stollenwerk, Björn
(2014):
Should health insurers target prevention of cardiovascular disease? A cost-effectiveness analysis of an individualised programme in Germany based on routine data.
In: BMC Health Services Research
14:263
[PDF, 761kB]
Witt, Sabine; Leidl, Reiner ORCID: https://orcid.org/0000-0002-7115-7510; Becker, Christian; Holle, Rolf; Block, Michael; Brachmann, Johannes; Silber, Sigmund und Stollenwerk, Björn
(2014):
The Effectiveness of the Cardiovascular Disease Prevention Programme 'KardioPro' Initiated by a German Sickness Fund: A Time-to-Event Analysis of Routine Data.
In: PLOS ONE 9(12), e114720 [PDF, 554kB]
ORCID: https://orcid.org/0000-0002-7115-7510; Becker, Christian; Holle, Rolf; Block, Michael; Brachmann, Johannes; Silber, Sigmund und Stollenwerk, Björn
(2014):
The Effectiveness of the Cardiovascular Disease Prevention Programme 'KardioPro' Initiated by a German Sickness Fund: A Time-to-Event Analysis of Routine Data.
In: PLOS ONE 9(12), e114720 [PDF, 554kB]